BioNTech SE
BioNTech SE
Community score
+2.04
Industry: Biotechnology & Pharmaceuticals
Listing country:
United States
Year added:
2023
BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Rhineland-Palatinate, Germany. The company primarily focuses on various business segments such as mRNA therapies, Therapeutics, Vaccines, Oncology, Infectious diseases, and Personalized Medicine. Its most significant product to date is the Pfizer-BioNTech COVID-19 vaccine, also known as Comirnaty (BNT162b2). BioNTech's products, which include the globally recognized COVID-19 vaccine, are sold worldwide, with key markets in the United States, European Union member countries, and numerous other locations through international agreements and partnerships. (Powered by AI)
Show Company Information
You view a limited profile page without scores and metrics
availability. Subscribing users get to see more advanced data, want to
see it in action? Click on a company you are interested in:
.